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Background
T h ea r g i n a s ei s o z y m e s( a r g i n a s e1a n d2 ) ,c o n v e r tL -
arginine into L-ornithine and urea, and thus compete
w i t ht h en i t r i co x i d es y n t h a s ei s o z y m e sf o rs u b s t r a t e .
We have previously shown that arginase 1 expression is
upregulated in human asthma and plays a functional
role in airways hyperresponsiveness (AHR) in an animal
model of allergic airways inflammation. Ambient parti-
cles and ozone are major constituents of urban air pol-
lution and contribute to asthma exacerbations. However,
the mechanisms underlying the exacerbation of allergic
airways disease by air pollution remain to be elucidated.
There is evidence that arginase expression is augmented
in cigarette smoking asthmatics. We tested the hypoth-
esis that arginase is involved in the exacerbation of
respiratory symptoms in response to air pollution in ani-
mal models of allergic airways inflammation.
Methods
We used sub-acute (16-day) and chronic (12-week)
murine models of ovalbumin (OVA)-induced allergic
airways inflammation as models of asthma. All mice
were sensitized to OVA, and then randomized to aero-
sol challenge with PBS (control; OVA/PBS) or OVA
(allergic airways inflammation; OVA/OVA). Twenty-
four hours after the final OVA or PBS challenge, mice
underwent a combined exposure to concentrated ambi-
ent fine particles plus ozone (CAP+O3), or filtered air.
Following exposure, mice were treated with either the
arginase inhibitor S-boronoethyl l-cysteine (BEC; 40 μg/
g b.w.), or vehicle (PBS), by direct nebulization into the
airways. After determination of the airways responsive-
ness to methacholine using the flexiVent, tissues were
harvested for Western blotting, activity testing and
immunohistochemistry.
Results
Exposure to CAP+O3 augmented the AHR in the OVA/
OVA mice with no significant effect on the OVA/PBS
controls in both the sub-acute and chronic models.
Expression of arginase 1 and total arginase activity were
significantly augmented in OVA/OVA mice exposed to
CAP+O3, compared to filtered air. Immunohistochemis-
try revealed that arginase 1 expression was specifically
up-regulated in the peribronchiolar region following
CAP+O3 exposure in OVA/OVA mice. Treatment with
BEC significantly reduced the pollution-induced AHR in
CAP+O3-exposed OVA/OVA mice in both the sub-
acute and chronic murine models to control levels.
Conclusions
This study demonstrates that arginase 1 is up-regulated
following environmental exposures in murine models of
allergic airways inflammation. Attenuation of airways
hyperresponsiveness by arginase inhibition suggests that
this pathway is a promising candidate for future thera-
pies to prevent or treat air pollution-induced exacerba-
tion of allergic symptoms.
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